Valuation: Becton, Dickinson and Company

Market Cap 4.21TCr 3.68TCr 3.38TCr 3.15TCr 5.98TCr 4,01100Cr 6.08TCr 41TCr 16TCr 1,96700Cr 16TCr 15TCr 6,77900Cr P/E 2026 *
38.1x
P/E 2027 * 29.4x
Enterprise Value 5.81TCr 5.08TCr 4.66TCr 4.35TCr 8.24TCr 5,53000Cr 8.38TCr 56TCr 22TCr 2,71200Cr 22TCr 21TCr 9,34600Cr EV / Sales 2026 *
3.02x
EV / Sales 2027 * 2.85x
Free-Float
74.04%
Yield 2026 *
2.52%
Yield 2027 * 2.56%
1 day+3.39%
1 week+4.43%
Current month+4.46%
1 month+9.45%
3 months+2.31%
6 months-18.91%
Current year-18.54%
1 week 149.69
Extreme 149.69
158.72
1 month 140.11
Extreme 140.11
158.72
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
287.32
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
26/06Sell

Executive/Senior Manager

-75 0.0000%
24/06Sell

Executive/Senior Manager

-1,100 0.0004%
22/06Other

EVP and Chief People Officer

39,984 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
+3.39%+4.43%-10.83%-39.65% 4.21TCr
+3.48%+2.31%-28.87%-11.03% 16TCr
+5.04%+3.32%-5.77%-4.53% 10TCr
+2.80%+3.33%+1.83%+55.31% 5.61TCr
-1.22%-2.88%+53.69%+49.87% 5.34TCr
+3.50%+14.35% - - 3.53TCr
+3.47%+3.79%-14.75%-43.91% 2.66TCr
+0.20%+5.53%+65.33%-3.33% 2.58TCr
+2.78%+3.61%-8.42%-0.43% 2.07TCr
+2.69%+1.40%-14.89%-2.92% 1.96TCr
Average +2.32%+2.67%+4.15%-0.07% 5.41TCr
Weighted average by Cap. +2.57%+1.89%-3.72%+1.08%

Financials

2026 *2027 *
Net sales 1.92TCr 1.68TCr 1.54TCr 1.44TCr 2.72TCr 1,82800Cr 2.77TCr 19TCr 7.19TCr 90TCr 7.21TCr 7.05TCr 3,09000Cr 1.97TCr 1.72TCr 1.58TCr 1.47TCr 2.8TCr 1,87600Cr 2.84TCr 19TCr 7.38TCr 92TCr 7.4TCr 7.24TCr 3,17100Cr
Net income 112.46Cr 98Cr 90Cr 84Cr 159.54Cr 11TCr 162.23Cr 1.09TCr 421.07Cr 5.25TCr 422.28Cr 413.1Cr 18TCr 144.92Cr 126.63Cr 116.28Cr 108.44Cr 205.58Cr 14TCr 209.05Cr 1.4TCr 542.6Cr 6.77TCr 544.15Cr 532.33Cr 23TCr
Net Debt 1.6TCr 1.39TCr 1.28TCr 1.19TCr 2.26TCr 1,51900Cr 2.3TCr 15TCr 5.97TCr 75TCr 5.99TCr 5.86TCr 2,56700Cr 1.41TCr 1.23TCr 1.13TCr 1.05TCr 2TCr 1,34000Cr 2.03TCr 14TCr 5.27TCr 66TCr 5.28TCr 5.17TCr 2,26400Cr
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
03/26/03 $158.08 +3.39% 20,29,718
01/26/01 $152.90 +1.04% 21,31,647
30/26/30 $151.33 -2.49% 21,09,075
29/26/29 $155.19 -0.47% 23,96,596
26/26/26 $155.92 +3.00% 1,21,80,748
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
152.90USD
Average target price
177.75USD
Spread / Average Target
+16.25%

Quarterly revenue - Rate of surprise